BAG3 Down-Modulation Reduces Anaplastic Thyroid Tumor Growth by Enhancing Proteasome-Mediated Degradation of BRAF Protein

Context:Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis through multiple mechanisms.Objective:The objective of the study was the investigation of the influence of B-cell lymphoma-2-associate...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 97; no. 1; pp. E115 - E120
Main Authors Chiappetta, Gennaro, Basile, Anna, Arra, Claudio, Califano, Daniela, Pasquinelli, Rosa, Barbieri, Antonio, De Simone, Veronica, Rea, Domenica, Giudice, Aldo, Pezzullo, Luciano, De Laurenzi, Vincenzo, Botti, Gerardo, Losito, Simona, Conforti, Daniela, Turco, Maria Caterina
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.01.2012
Copyright by The Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Context:Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis through multiple mechanisms.Objective:The objective of the study was the investigation of the influence of B-cell lymphoma-2-associated athanogene 3 (BAG3) on ATC growth.Design and Subjects:We investigated the effects of BAG3 down-modulation, obtained by using a specific small interfering RNA, on in vitro and in vivo growth of the human ATC cell line 8505C. Because BRAF protein plays an important role in ATC cell growth, we analyzed the effects of BAG3 down-modulation on BRAF protein levels. Furthermore, by using a proteasome inhibitor, we verified whether BAG3-mediated regulation of BRAF levels involved a proteasome-dependent mechanism.Results:BAG3 down-modulation significantly inhibits ATC growth in vitro and in vivo. BAG3 coimmunoprecipitates with BRAF protein, and its down-modulation results in a significant reduction of BRAF protein levels, which can be reverted by incubation with the proteasome inhibitor MG132.Conclusion:BAG3 protein sustains ATC growth in vitro and in vivo. The underlying molecular mechanism appears to rely on BAG3 binding to BRAF, thus protecting it from proteasome-dependent degradation. These results are in line with the reported ability of BAG3 to interfere with the proteasomal delivery of a number of other client proteins.
AbstractList Context:Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis through multiple mechanisms.Objective:The objective of the study was the investigation of the influence of B-cell lymphoma-2-associated athanogene 3 (BAG3) on ATC growth.Design and Subjects:We investigated the effects of BAG3 down-modulation, obtained by using a specific small interfering RNA, on in vitro and in vivo growth of the human ATC cell line 8505C. Because BRAF protein plays an important role in ATC cell growth, we analyzed the effects of BAG3 down-modulation on BRAF protein levels. Furthermore, by using a proteasome inhibitor, we verified whether BAG3-mediated regulation of BRAF levels involved a proteasome-dependent mechanism.Results:BAG3 down-modulation significantly inhibits ATC growth in vitro and in vivo. BAG3 coimmunoprecipitates with BRAF protein, and its down-modulation results in a significant reduction of BRAF protein levels, which can be reverted by incubation with the proteasome inhibitor MG132.Conclusion:BAG3 protein sustains ATC growth in vitro and in vivo. The underlying molecular mechanism appears to rely on BAG3 binding to BRAF, thus protecting it from proteasome-dependent degradation. These results are in line with the reported ability of BAG3 to interfere with the proteasomal delivery of a number of other client proteins.
Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis through multiple mechanisms.CONTEXTAnaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis through multiple mechanisms.The objective of the study was the investigation of the influence of B-cell lymphoma-2-associated athanogene 3 (BAG3) on ATC growth.OBJECTIVEThe objective of the study was the investigation of the influence of B-cell lymphoma-2-associated athanogene 3 (BAG3) on ATC growth.We investigated the effects of BAG3 down-modulation, obtained by using a specific small interfering RNA, on in vitro and in vivo growth of the human ATC cell line 8505C. Because BRAF protein plays an important role in ATC cell growth, we analyzed the effects of BAG3 down-modulation on BRAF protein levels. Furthermore, by using a proteasome inhibitor, we verified whether BAG3-mediated regulation of BRAF levels involved a proteasome-dependent mechanism.DESIGN AND SUBJECTSWe investigated the effects of BAG3 down-modulation, obtained by using a specific small interfering RNA, on in vitro and in vivo growth of the human ATC cell line 8505C. Because BRAF protein plays an important role in ATC cell growth, we analyzed the effects of BAG3 down-modulation on BRAF protein levels. Furthermore, by using a proteasome inhibitor, we verified whether BAG3-mediated regulation of BRAF levels involved a proteasome-dependent mechanism.BAG3 down-modulation significantly inhibits ATC growth in vitro and in vivo. BAG3 coimmunoprecipitates with BRAF protein, and its down-modulation results in a significant reduction of BRAF protein levels, which can be reverted by incubation with the proteasome inhibitor MG132.RESULTSBAG3 down-modulation significantly inhibits ATC growth in vitro and in vivo. BAG3 coimmunoprecipitates with BRAF protein, and its down-modulation results in a significant reduction of BRAF protein levels, which can be reverted by incubation with the proteasome inhibitor MG132.BAG3 protein sustains ATC growth in vitro and in vivo. The underlying molecular mechanism appears to rely on BAG3 binding to BRAF, thus protecting it from proteasome-dependent degradation. These results are in line with the reported ability of BAG3 to interfere with the proteasomal delivery of a number of other client proteins.CONCLUSIONBAG3 protein sustains ATC growth in vitro and in vivo. The underlying molecular mechanism appears to rely on BAG3 binding to BRAF, thus protecting it from proteasome-dependent degradation. These results are in line with the reported ability of BAG3 to interfere with the proteasomal delivery of a number of other client proteins.
CONTEXT:Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis through multiple mechanisms. OBJECTIVE:The objective of the study was the investigation of the influence of B-cell lymphoma-2-associated athanogene 3 (BAG3) on ATC growth. DESIGN AND SUBJECTS:We investigated the effects of BAG3 down-modulation, obtained by using a specific small interfering RNA, on in vitro and in vivo growth of the human ATC cell line 8505C. Because BRAF protein plays an important role in ATC cell growth, we analyzed the effects of BAG3 down-modulation on BRAF protein levels. Furthermore, by using a proteasome inhibitor, we verified whether BAG3-mediated regulation of BRAF levels involved a proteasome-dependent mechanism. RESULTS:BAG3 down-modulation significantly inhibits ATC growth in vitro and in vivo. BAG3 coimmunoprecipitates with BRAF protein, and its down-modulation results in a significant reduction of BRAF protein levels, which can be reverted by incubation with the proteasome inhibitor MG132. CONCLUSION:BAG3 protein sustains ATC growth in vitro and in vivo. The underlying molecular mechanism appears to rely on BAG3 binding to BRAF, thus protecting it from proteasome-dependent degradation. These results are in line with the reported ability of BAG3 to interfere with the proteasomal delivery of a number of other client proteins.
Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis through multiple mechanisms. The objective of the study was the investigation of the influence of B-cell lymphoma-2-associated athanogene 3 (BAG3) on ATC growth. We investigated the effects of BAG3 down-modulation, obtained by using a specific small interfering RNA, on in vitro and in vivo growth of the human ATC cell line 8505C. Because BRAF protein plays an important role in ATC cell growth, we analyzed the effects of BAG3 down-modulation on BRAF protein levels. Furthermore, by using a proteasome inhibitor, we verified whether BAG3-mediated regulation of BRAF levels involved a proteasome-dependent mechanism. BAG3 down-modulation significantly inhibits ATC growth in vitro and in vivo. BAG3 coimmunoprecipitates with BRAF protein, and its down-modulation results in a significant reduction of BRAF protein levels, which can be reverted by incubation with the proteasome inhibitor MG132. BAG3 protein sustains ATC growth in vitro and in vivo. The underlying molecular mechanism appears to rely on BAG3 binding to BRAF, thus protecting it from proteasome-dependent degradation. These results are in line with the reported ability of BAG3 to interfere with the proteasomal delivery of a number of other client proteins.
Author De Simone, Veronica
Chiappetta, Gennaro
Pezzullo, Luciano
Basile, Anna
De Laurenzi, Vincenzo
Botti, Gerardo
Califano, Daniela
Conforti, Daniela
Rea, Domenica
Turco, Maria Caterina
Arra, Claudio
Pasquinelli, Rosa
Barbieri, Antonio
Giudice, Aldo
Losito, Simona
AuthorAffiliation Functional Genomic Unit (G.C., D.C., R.P., V.D.S.), Animal Facility (C.A., A.B., D.R., A.G.), Thyroid and Parathyroid Surgery (L.P.), and Pathology Department (G.B., S.L.), National Cancer Institute, Fondazione G. Pascale, 80131 Naples, Italy; Department of Pharmaceutical Sciences (A.B., D.C., M.C.T.), University of Salerno, 84084 Fisciano, Italy; and Department of Biomedical Sciences (V.D.L.), University of Chieti-Pescara, 66100 Chieti, Italy
AuthorAffiliation_xml – name: Functional Genomic Unit (G.C., D.C., R.P., V.D.S.), Animal Facility (C.A., A.B., D.R., A.G.), Thyroid and Parathyroid Surgery (L.P.), and Pathology Department (G.B., S.L.), National Cancer Institute, Fondazione G. Pascale, 80131 Naples, Italy; Department of Pharmaceutical Sciences (A.B., D.C., M.C.T.), University of Salerno, 84084 Fisciano, Italy; and Department of Biomedical Sciences (V.D.L.), University of Chieti-Pescara, 66100 Chieti, Italy
Author_xml – sequence: 1
  givenname: Gennaro
  surname: Chiappetta
  fullname: Chiappetta, Gennaro
  email: chiappetta.gennaro@gmail.com
  organization: 1Functional Genomic Unit (G.C., D.C., R.P., V.D.S.),80131 Naples, Italy
– sequence: 2
  givenname: Anna
  surname: Basile
  fullname: Basile, Anna
  organization: 2Animal Facility (C.A., A.B., D.R., A.G.), 80131 Naples, Italy
– sequence: 3
  givenname: Claudio
  surname: Arra
  fullname: Arra, Claudio
  organization: 2Animal Facility (C.A., A.B., D.R., A.G.), 80131 Naples, Italy
– sequence: 4
  givenname: Daniela
  surname: Califano
  fullname: Califano, Daniela
  organization: 1Functional Genomic Unit (G.C., D.C., R.P., V.D.S.),80131 Naples, Italy
– sequence: 5
  givenname: Rosa
  surname: Pasquinelli
  fullname: Pasquinelli, Rosa
  organization: 1Functional Genomic Unit (G.C., D.C., R.P., V.D.S.),80131 Naples, Italy
– sequence: 6
  givenname: Antonio
  surname: Barbieri
  fullname: Barbieri, Antonio
  organization: 2Animal Facility (C.A., A.B., D.R., A.G.), 80131 Naples, Italy
– sequence: 7
  givenname: Veronica
  surname: De Simone
  fullname: De Simone, Veronica
  organization: 1Functional Genomic Unit (G.C., D.C., R.P., V.D.S.),80131 Naples, Italy
– sequence: 8
  givenname: Domenica
  surname: Rea
  fullname: Rea, Domenica
  organization: 2Animal Facility (C.A., A.B., D.R., A.G.), 80131 Naples, Italy
– sequence: 9
  givenname: Aldo
  surname: Giudice
  fullname: Giudice, Aldo
  organization: 2Animal Facility (C.A., A.B., D.R., A.G.), 80131 Naples, Italy
– sequence: 10
  givenname: Luciano
  surname: Pezzullo
  fullname: Pezzullo, Luciano
  organization: 3Thyroid and Parathyroid Surgery (L.P.), 80131 Naples, Italy
– sequence: 11
  givenname: Vincenzo
  surname: De Laurenzi
  fullname: De Laurenzi, Vincenzo
  organization: 6Department of Biomedical Sciences (V.D.L.), University of Chieti-Pescara, 66100 Chieti, Italy
– sequence: 12
  givenname: Gerardo
  surname: Botti
  fullname: Botti, Gerardo
  organization: 4Pathology Department (G.B., S.L.), National Cancer Institute, Fondazione G. Pascale, 80131 Naples, Italy
– sequence: 13
  givenname: Simona
  surname: Losito
  fullname: Losito, Simona
  organization: 4Pathology Department (G.B., S.L.), National Cancer Institute, Fondazione G. Pascale, 80131 Naples, Italy
– sequence: 14
  givenname: Daniela
  surname: Conforti
  fullname: Conforti, Daniela
  organization: 1Functional Genomic Unit (G.C., D.C., R.P., V.D.S.),80131 Naples, Italy
– sequence: 15
  givenname: Maria Caterina
  surname: Turco
  fullname: Turco, Maria Caterina
  organization: 5Department of Pharmaceutical Sciences (A.B., D.C., M.C.T.), University of Salerno, 84084 Fisciano, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22072743$$D View this record in MEDLINE/PubMed
BookMark eNp1kt1r2zAUxcXoWNNub3segj3sZer0Zct-TL-yQctGyWBvQpGua2eOlEo2If_9lLrboFAhIQl-53B1j07QkQ8eEHrP6BnjjH5Z2zNOGSNUVvIVmrFaFkSxWh2hGaWckVrxX8foJKU1pUzKQrxBx5xTxZUUM7Q_ny8Evgw7T26DG3szdMHjO3CjhYTn3mx7k4bO4mW7j6FzeDluQsSLGHZDi1d7fOVb423n7_GPGAYwKWyA3ILrzAAOX8J9NG4yDQ0-v5tfT1zn36LXjekTvHvaT9HP66vlxVdy833x7WJ-Q6yoC0qcqq1pVMOboljVTSWV40ZWFqBWtChXQgnJwVFHocqHsuGOlbwqeVmCtLQQp-jT5LuN4WGENOhNlyz0vfEQxqRrJkslKKOZ_PiMXIcx-lycFqyUUqiiOPh9eKLG1Qac3sZuY-Je_-1pBj5PgI0hpQjNP4RRfYhMr60-RKYPkWWcP8NtNzx2bIim618SyUm0C_0AMf3uxx1E3YLph1bTPPKjKpIFeeYbyauk_3sRxu1LVT1-JPEHaxazLA
CitedBy_id crossref_primary_10_1038_s41416_021_01446_2
crossref_primary_10_1038_cddis_2014_32
crossref_primary_10_1172_JCI149415
crossref_primary_10_1016_j_taap_2022_116067
crossref_primary_10_1007_s12032_016_0862_5
crossref_primary_10_1016_j_bbcan_2012_06_001
crossref_primary_10_1007_s13273_017_0010_0
crossref_primary_10_1097_CCO_0b013e32835c1381
crossref_primary_10_3390_ijms24119148
crossref_primary_10_1038_cddis_2016_321
crossref_primary_10_1002_cbin_12199
crossref_primary_10_3390_biomedicines10081994
crossref_primary_10_1186_s12885_018_4657_2
crossref_primary_10_1002_1878_0261_12492
crossref_primary_10_4161_15384101_2014_952959
crossref_primary_10_18632_oncotarget_23858
crossref_primary_10_18632_oncotarget_9039
crossref_primary_10_1016_j_bbagen_2020_129628
crossref_primary_10_1016_j_semcdb_2017_08_049
crossref_primary_10_1155_2019_9734576
crossref_primary_10_18632_oncotarget_2261
crossref_primary_10_1371_journal_pone_0226199
crossref_primary_10_1210_jc_2014_1779
crossref_primary_10_18632_oncotarget_18902
crossref_primary_10_1016_j_pharmthera_2020_107498
crossref_primary_10_3390_cancers14174168
crossref_primary_10_1186_1297_9716_44_61
ContentType Journal Article
Copyright Copyright © 2012 by The Endocrine Society 2012
Copyright © 2012 by The Endocrine Society
Copyright_xml – notice: Copyright © 2012 by The Endocrine Society 2012
– notice: Copyright © 2012 by The Endocrine Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7X8
DOI 10.1210/jc.2011-0484
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage E120
ExternalDocumentID 22072743
10_1210_jc_2011_0484
00004678-201201000-00060
10.1210/jc.2011-0484
Genre Research Support, Non-U.S. Gov't
Journal Article
Report
GroupedDBID ---
-~X
.55
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
4.4
48X
53G
5GY
5RS
5YH
8F7
AABZA
AACZT
AAIMJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
ABBLC
ABDFA
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVV
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFZL
AFGWE
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGQXC
AGUTN
AHMBA
AHMMS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BSWAC
BTRTY
C45
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EJD
EMOBN
ENERS
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
HZ~
H~9
KBUDW
KOP
KQ8
KSI
KSN
L7B
M5~
MHKGH
MJL
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
REU
ROX
ROZ
TEORI
TJX
TLC
TR2
TWZ
VVN
W8F
WOQ
X7M
YBU
YFH
YHG
YOC
YSK
ZY1
~02
~H1
.GJ
3O-
7X7
88E
8FI
8FJ
AAJQQ
AAKAS
AAPGJ
AAQQT
AAUQX
AAWDT
AAYJJ
ABDPE
ABUWG
ABXZS
ACFRR
ACVCV
ACZBC
ADMTO
ADNBA
ADZCM
AEMQT
AEOTA
AERZD
AFFNX
AFFQV
AFKRA
AFYAG
AGMDO
AGORE
AHGBF
AI.
AJBYB
AJDVS
ALXQX
APJGH
AQDSO
AQKUS
AVNTJ
BENPR
BPHCQ
BVXVI
CCPQU
EIHJH
FEDTE
FYUFA
HMCUK
HVGLF
IAO
IHR
INH
ITC
J5H
M1P
MBLQV
N4W
NU-
OBFPC
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
TMA
UKHRP
VH1
WHG
X52
ZGI
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7X8
ID FETCH-LOGICAL-c3950-d79caf7f2f55b9f847d2a48cee97056b37342ed0d0e842e6f2d16286266e4c053
ISSN 0021-972X
1945-7197
IngestDate Fri Jul 11 16:02:30 EDT 2025
Mon Jun 30 12:43:06 EDT 2025
Thu Apr 03 07:08:29 EDT 2025
Tue Jul 01 00:49:54 EDT 2025
Thu Apr 24 23:08:49 EDT 2025
Fri May 16 04:03:20 EDT 2025
Fri Feb 07 10:35:39 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3950-d79caf7f2f55b9f847d2a48cee97056b37342ed0d0e842e6f2d16286266e4c053
Notes SourceType-Scholarly Journals-1
content type line 14
ObjectType-Report-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 22072743
PQID 3164437555
PQPubID 2046206
ParticipantIDs proquest_miscellaneous_914673010
proquest_journals_3164437555
pubmed_primary_22072743
crossref_primary_10_1210_jc_2011_0484
crossref_citationtrail_10_1210_jc_2011_0484
wolterskluwer_health_00004678-201201000-00060
oup_primary_10_1210_jc_2011-0484
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20120101
2012-January
2012-01-00
2012-Jan
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 20120101
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2012
Publisher Oxford University Press
Copyright by The Endocrine Society
Publisher_xml – name: Oxford University Press
– name: Copyright by The Endocrine Society
SSID ssj0014453
Score 2.1943734
Snippet Context:Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell...
CONTEXT:Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell...
Anaplastic thyroid tumors (ATC) express high levels of BAG3, a member of the BAG family of cochaperone proteins that is involved in regulating cell apoptosis...
SourceID proquest
pubmed
crossref
wolterskluwer
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage E115
SubjectTerms Adaptor Proteins, Signal Transducing - antagonists & inhibitors
Adaptor Proteins, Signal Transducing - genetics
Adaptor Proteins, Signal Transducing - metabolism
Adaptor Proteins, Signal Transducing - physiology
Animals
Apoptosis
Apoptosis Regulatory Proteins
B-cell lymphoma
Cell Growth Processes - genetics
Cell Line, Tumor
Down-Regulation - genetics
Female
Gene Expression Regulation, Neoplastic - drug effects
Humans
Lymphocytes B
Mice
Mice, Nude
Molecular modelling
Proteasome Endopeptidase Complex - drug effects
Proteasome Endopeptidase Complex - metabolism
Proteasome Endopeptidase Complex - physiology
Proteasome inhibitors
Proteasomes
Protein Binding - drug effects
Proteins
Proteolysis - drug effects
Proto-Oncogene Proteins B-raf - genetics
Proto-Oncogene Proteins B-raf - metabolism
RNA, Small Interfering - pharmacology
siRNA
Thyroid
Thyroid Carcinoma, Anaplastic
Thyroid gland
Thyroid Neoplasms - genetics
Thyroid Neoplasms - metabolism
Thyroid Neoplasms - pathology
Up-Regulation - drug effects
Up-Regulation - genetics
Xenograft Model Antitumor Assays
Title BAG3 Down-Modulation Reduces Anaplastic Thyroid Tumor Growth by Enhancing Proteasome-Mediated Degradation of BRAF Protein
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201201000-00060
https://www.ncbi.nlm.nih.gov/pubmed/22072743
https://www.proquest.com/docview/3164437555
https://www.proquest.com/docview/914673010
Volume 97
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKkBAIIb4pDOQHeJoy5cNumsdudBug8oA6aW-REztrx5pUaaOq_EP-FffabpKOVWK8RFFrJY7viX2uc8-9hHzk0Dvex2R4PAscBgzbEa6AF4_7kvFA9GWCQuHR997ZOft6wS86nd-tqKVqmRymv27VlfyPVeE3sCuqZO9g2fqi8AOcg33hCBaG4z_Z-GhwGgAFXuXOqJC2DhcMmKwwzGqQizlQY0zIOp6sy2IqD8bVrChxu2m1nCDvHOYTTLeRX6JeAKy9KGbKGeniHQoDlC9LIWtKefRjcGLa2WTdVw3QWvknaqmlymUBU1LeJHmaqSVA7nqTtFAHFUzFHHi7obCnMOmLsmg2VxdTE-yMWZ4bZOrKSFjNs5LTurHWmAldR9zK5kV7Q0NHhrQ3NI6L-VpvTOA44CMMbXfVJpC1PZ9jgEmoC7LX87mJ993CrZmch55RjtqFfuhpGd7fiwh4wbiIpIdm_9gkW72Zlls7V7DSO_gIrmcF-j33Hrnvg8eCxTQ-f_lWf9BizCZEtR22GgwUULVvtMWOthSXLcfnEXm8KjCWYvFTSylahGj8lDyxngwdGFg-Ix2VPycPRjZW4wVZIzrpDXRSi07aoJNadFKNTmrQSZM1rdFJb0EnbaGTFhlFdFKLzpfk_GQ4Pj5zbKEPJw0i7joyjFKRhZmfcZ5EGRAm6QvWB_4WhUDQkyAMmK-kK13Vh5Ne5ksPJdVALhVLYRl5RfbyIldvCIWBToB08swTKZNemHgsUT1gYEnEeoq7XXKwGeA4tVnwsRjLdYzeMJgjvkpjNEeM5uiST3Xrucn-sqMdBVvtauKYJvsbQ8b2pVzEgQfuSBByzuEK9d8wweNXO5GrolrEEXIZWIah66-N_ev7-L4L7gcLusTZAkRsNNTxLoy-vWP7d-Rh86Luk71lWan3wMWXyQeN8j_kytof
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BAG3+Down-Modulation+Reduces+Anaplastic+Thyroid+Tumor+Growth+by+Enhancing+Proteasome-Mediated+Degradation+of+BRAF+Protein&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Chiappetta%2C+Gennaro&rft.au=Basile%2C+Anna&rft.au=Arra%2C+Claudio&rft.au=Califano%2C+Daniela&rft.date=2012-01-01&rft.pub=Copyright+by+The+Endocrine+Society&rft.issn=0021-972X&rft.volume=97&rft.issue=1&rft.spage=E115&rft.epage=E120&rft_id=info:doi/10.1210%2Fjc.2011-0484&rft.externalDocID=00004678-201201000-00060
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon